Whole-body diffusion magnetic resonance imaging in the assessment of lymphoma

Cancer Imaging

Volumn 12, Issue 2, 2012, Pages 403-408

  Lin, Chieh ^a   Luciani, Alain ^b   Itti, Emmanuel ^b   Haioun, Corinne ^b   Safar, Violaine ^b   Meignan, Michel ^b   Rahmouni, Alain ^b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b HENRI MONDOR HOSPITAL   (France)

Author keywords

FDG PET CT; Lymphoma; Response assessment; Staging; Whole body diffusion MRI

Indexed keywords

CONTRAST MEDIUM;

CANCER CHEMOTHERAPY; CANCER STAGING; CLINICAL ASSESSMENT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIFFUSION WEIGHTED IMAGING; FOLLOW UP; HODGKIN DISEASE; HUMAN; IMAGE ANALYSIS; IONIZING RADIATION; LYMPHOMA; REVIEW; SIGNAL NOISE RATIO; WHOLE BODY IMAGING;

DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; LYMPHATIC METASTASIS; LYMPHOMA; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; WHOLE BODY IMAGING;

EID: 84867902791     PISSN: None     EISSN: 14707330     Source Type: Journal    
DOI: 10.1102/1470-7330.2012.9048     Document Type: Review

References (23)

1. Cheson BD, Pfistner B, Juweid ME, et al. Revised response criteria for malignant lymphoma. J Clin Oncol 2007; 25: 579-586. doi:10.1200/JCO.2006.09. 2403. PMid:17242396.
2. Juweid ME, Stroobants S, Hoekstra OS, et al. Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol 2007; 25: 571-578. doi:10.1200/JCO.2006.08.2305. PMid:17242397.
3. Nakayama T, Yoshimitsu K, Irie H, et al. Usefulness of the calculated apparent diffusion coefficient value in the differential diagnosis of retroperitoneal masses. J Magn Reson Imaging 2004; 20: 735-742. doi:10.1002/jmri.20149. PMid:15390151.
4. Sumi M, Ichikawa Y, Nakamura T. Diagnostic ability of apparent diffusion coefficients for lymphomas and carcinomas in the pharynx. Eur Radiol 2007; 17: 2631-2637. doi:10.1007/s00330-007-0588-z. PMid:17429643.
5. Toh CH, Castillo M, Wong AM, et al. Primary cerebral lymphoma and glioblastoma multiforme: differences in diffusion characteristics evaluated with diffusion tensor imaging. AJNR Am J Neuroradiol 2008; 29: 471-475. doi:10.3174/ajnr.A0872. PMid:18065516.
6. Takahara T, Imai Y, Yamashita T, Yasuda S, Nasu S, Van Cauteren M. Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. Radiat Med 2004; 22: 275-282. PMid:15468951.
7. Kwee TC, Takahara T, Ochiai R, Nievelstein RA, Luijten PR. Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology. Eur Radiol 2008; 18: 1937-1952. doi:10.1007/s00330-008-0968-z. PMid:18446344.
8. Padhani AR, Koh DM, Collins DJ. Whole-body diffusion-weighted MR imaging in cancer: current status and research directions. Radiology 2011; 261: 700-718. doi:10.1148/radiol.11110474. PMid:22095994.
9. Koh DM, Takahara T, Imai Y, Collins DJ. Practical aspects of assessing tumors using clinical diffusion-weighted imaging in the body. Magn Reson Med Sci 2007; 6: 211-224. doi:10.2463/mrms.6.211. PMid:18239358.
10. Lin C, Luciani A, Itti E, et al. Whole-body diffusion-weighted magnetic resonance imaging with apparent diffusion coefficient mapping for staging patients with diffuse large B-cell lymphoma. Eur Radiol; 20: 2027-2038. doi:10.1007/s00330-010-1758-y. PMid:20309558.
11. Lin C, Itti E, Luciani A, Haioun C, Meignan M, Rahmouni A. Whole-body diffusion-weighted imaging in lymphoma. Cancer Imaging 2010; 10: S172-178. doi:10.1102/1470-7330.2010.9029. PMid:20880782.
12. Kwee TC, Quarles van Ufford HM, Beek FJ, et al. Whole-body MRI, including diffusion-weighted imaging, for the initial staging of malignant lymphoma: comparison to computed tomography. Invest Radiol 2009; 44: 683-690. doi:10.1097/RLI.0b013e3181afbb36. PMid:19724232.
13. Kwee TC, Takahara T, Vermoolen MA, Bierings MB, Mali WP, Nievelstein RA. Whole-body diffusion-weighted imaging for staging malignant lymphoma in children. Pediatr Radiol 2010; 40: 1592-1602; quiz 1720-1591. doi:10.1007/s00247-010-1775-7. PMid:20676622.
14. 18F-FDG PET/CT. AJR Am J Roentgenol 2011; 196: 662-669. doi:10.2214/AJR.10.4743. PMid:21343511.
15. Abdulqadhr G, Molin D, Astrom G, et al. Whole-body diffusion-weighted imaging compared with FDG-PET/CT in staging of lymphoma patients. Acta Radiol 2011; 52: 173-180. doi:10.1258/ar.2010.100246. PMid:21498346.
16. Lin C, Itti E, Luciani A, et al. Whole-body diffusion-weighted imaging with apparent diffusion coefficient mapping for treatment response assessment in patients with diffuse large B-cell lymphoma: pilot study. Invest Radiol 2011; 46: 341-349. PMid:21263330.
17. Gu J, Chan T, Zhang J, Leung AY, Kwong YL, Khong PL. Whole-body diffusion-weighted imaging: the added value to whole-body MRI at initial diagnosis of lymphoma. AJR Am J Roentgenol 2011; 197: W384-391. doi:10.2214/AJR.10.5692. PMid:21862763.
18. Wu X, Kellokumpu-Lehtinen PL, Pertovaara H, et al. Diffusion-weighted MRI in early chemotherapy response evaluation of patients with diffuse large B-cell lymphoma - a pilot study: comparison with 2-deoxy-2-fluoro-D-glucose-positron emission tomography/computed tomography. NMR Biomed 2011; 24: 1181-1190. doi:10.1002/nbm.1689. PMid:21387451.
19. Torabi M, Aquino SL, Harisinghani MG. Current concepts in lymph node imaging. J Nucl Med 2004; 45: 1509-1518. PMid:15347718.
20. Cheson BD, Horning SJ, Coiffier B, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol 1999; 17: 1244. PMid:10561185.
21. Kellenberger CJ, Miller SF, Khan M, Gilday DL, Weitzman S, Babyn PS. Initial experience with FSE STIR whole-body MR imaging for staging lymphoma in children. Eur Radiol 2004; 14: 1829-1841. PMid:15365752.
22. Punwani S, Taylor SA, Bainbridge A, et al. Pediatric and adolescent lymphoma: comparison of whole-body STIR half-Fourier RARE MR imaging with an enhanced PET/CT reference for initial staging. Radiology 2010; 255: 182-190. doi:10.1148/radiol.09091105. PMid:20308456.
23. Ustaalioglu BB, Seker M, Bilici A, et al. The role of PET-CT in the differential diagnosis of thymic mass after treatment of patients with lymphoma. Med Oncol 2011; 28: 258-264. doi:10.1007/s12032-010-9446-y. PMid:20155405.